EAU Guidelines on Diagnosis and Treatment of Upper Urinary Tract Transitional Cell Carcinoma von Oosterlinck, W, Solsona, E, van der Meijden, A.P.M, Sylvester, R, Böhle, A, Rintala, E, Lobel, B

Volltext

Optimal treatment for intermediate- and high-risk, nonmuscle-invasive bladder cancer von van der Meijden, A P M

Volltext

One Immediate Postoperative Instillation of Chemotherapy in Low Risk Ta, T1 Bladder Cancer Patients. Is it Always Safe? von Oddens, J.R, van der Meijden, A.P.M, Sylvester, R

Volltext

Treatment of Superficial Bladder Tumors: Achievements and Needs von Kurth, K.H., Bouffioux, C., Sylvester, R., van der Meijden, A.P.M., Oosterlinck, W., Brausi, M.

Volltext

Intravesical BCG in Patients with Carcinoma in situ of the Urinary Bladder: Long–Term Results of EORTC GU Group Phase II Protocol 30861 von Jakse, G., Hall, R., Bono, A., Höltl, W., Carpentier, P., Spaander, J.P., van der Meijden, A.P.M., Sylvester, R.

Volltext

New treatment approaches for superficial and invasive bladder cancer von Grossman, H.Barton, Debruyne, Frans M.J, Akaza, Hideyuki, Aso, Yoshio, Kagawa, Susumu, Kakehi, Yoshiyuki, van der Meijden, A.P.M, Ratliff, Timothy L

Volltext

The side effects of bacillus calmette-guerin in the treatment of TA Ti bladder cancer do not predict its efficacy: Results from an eortic genito-urinary group phase III trial von Sylvester, R., Van der Meijden, A.P.M., Oosterlinck, W., Casetta, G., Hoeltl, W., Bono, A.

Volltext

Screening for cervical Chlamydia trachomatis infections in two Dutch populations von Thewessen, E A, van der Meijden, W I, Doppenberg, H J, Mulder, P G, Wagenvoort, J H, Stolz, E, Michel, M F

Volltext